Gene therapy could prevent stillbirth and premature delivery
The first gene therapy to potentially reverse a significant cause of stillbirth and premature delivery is being developed by a team at University of Florida (UF) Health.
Up to one in 10 pregnancies in the developed world are affected by placental growth restriction, and twice that in the developing world.
The gene therapy created by Helen Jones, an Associate Professor in the UF College of Medicine’s Department of Physiology and Aging, and her team has shown promise in animal studies.
“This is a very exciting therapy,” Jones said. “We’re very happy with our results so far. If this goes well, it could be a game-changer for mothers worldwide. It has the potential to prevent so many premature births and give families hope that placental failure is not the early end of a pregnancy.”
Boosts placental function and reduces stress
The cause of placental insufficiency isn’t well understood, but the malfunctioning placentas have lower levels of a hormone called insulin-like growth factor 1. The gene therapy causes the placenta to produce higher quantities of the growth factor.
Insulin-like growth factor 1 also stimulates vascularisation, which translates to better nutrient transfer in the placenta.
The study shows that in guinea pigs, the therapy boosted placental function and delivery of normal-weight offspring. The treatment also reduced the mother’s levels of cortisol.
Too much stress during pregnancy can cause complications thought to contribute to high blood pressure, disruption of a foetus’ brain development, sleep deprivation, and mental health concerns such as depression and anxiety. It can trigger problems for mother and child even many years later, including cardiovascular disease and diabetes.
“A mother often has to work right up until delivery, and there’s nothing they can change about that,” said Jones. “They can’t just sit down and put their feet up. And while their doctors tell them to get more exercise, go outside, and not sit at their desks all day, we know that often doesn’t work in the real world. A treatment like ours could be life-changing in some pregnancies.”
Diana Spencer, Senior Digital Content Editor, DDW
